| 4001 | CA3 levels | GCST90468512 | 2.86 |
| 4002 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502410 | 2.86 |
| 4003 | BIN2/FYB1 ratio | GCST90313505 | 2.86 |
| 4004 | Cholesterol to total lipids ratio in small LDL | GCST90092957 | 2.86 |
| 4005 | Linoleic acid to total fatty acids percentage | GCST90502321 | 2.86 |
| 4006 | IDP T1 FAST ROIs R thalamus | GCST90002548 | 2.85 |
| 4007 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388 | ECGA000388 | 2.85 |
| 4008 | Fracture of forearm | FING00000554 | 2.85 |
| 4009 | MANF/TXNDC5 ratio | GCST90315370 | 2.85 |
| 4010 | FAM171B levels | GCST90090339 | 2.85 |
| 4011 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T91 | ECGA000091 | 2.85 |
| 4012 | Total Cholesteryl ester levels | GCST90025188 | 2.85 |
| 4013 | AKT1S1/TDRKH ratio | GCST90313233 | 2.85 |
| 4014 | KITLG levels | GCST90274833 | 2.85 |
| 4015 | MCFD2/VSIR ratio | GCST90315411 | 2.85 |
| 4016 | Disorders of lipid metabolism (PheCode 272) | GCST90475715 | 2.84 |
| 4017 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T283 | ECGA000283 | 2.84 |
| 4018 | Triglyceride levels in small VLDL | GCST90132667 | 2.84 |
| 4019 | AmygNuclei lh volume Accessory-Basal-nucleus | GCST90002650 | 2.83 |
| 4020 | SCLY levels | GCST90470546 | 2.83 |
| 4021 | LRIG3 levels | GCST90469795 | 2.83 |
| 4022 | Omega-3 fatty acid levels | GCST90502440 | 2.83 |
| 4023 | BDNF levels | GCST90468437 | 2.83 |
| 4024 | VASN levels | GCST90471027 | 2.82 |
| 4025 | NDUFB7 levels | GCST90470015 | 2.82 |
| 4026 | SEPTIN3 levels | GCST90470576 | 2.82 |
| 4027 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377 | ECGA000377 | 2.82 |
| 4028 | Body mass index | GCST90278622 | 2.82 |
| 4029 | Urine adenosine levels in chronic kidney disease | GCST90264757 | 2.82 |
| 4030 | FAM3B/FGF19 ratio | GCST90314776 | 2.82 |
| 4031 | PRKAR1A/SNAP23 ratio | GCST90315728 | 2.82 |
| 4032 | KDR levels | GCST90243323 | 2.82 |
| 4033 | N-delta-acetylornithine levels | GCST90200691 | 2.82 |
| 4034 | CDHR5 levels | GCST90468680 | 2.81 |
| 4035 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476365 | 2.81 |
| 4036 | GPRC5C levels | GCST90469398 | 2.81 |
| 4037 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 2.81 |
| 4038 | Heart rate variability (corrected root mean square of successive differences) | GCST90281264 | 2.81 |
| 4039 | Soft cheese liking | GCST90094843 | 2.80 |
| 4040 | T1 FreeSurfer DKT lh superiortemporal thickness | GCST90384252 | 2.80 |
| 4041 | SDK2 levels | GCST90470562 | 2.80 |
| 4042 | Feeling lonely | GCST006942 | 2.80 |
| 4043 | Blood cell traits latent factor 9 (white cell) | GCST90559251 | 2.80 |
| 4044 | VTI1A levels | GCST90471060 | 2.80 |
| 4045 | MAPK13 levels | GCST90241949 | 2.80 |
| 4046 | Gastric cancer | GCST90018629 | 2.80 |
| 4047 | ICAM5 levels | GCST90469502 | 2.79 |
| 4048 | DAAM1 levels | GCST90468941 | 2.79 |
| 4049 | GYS1/TIA1 ratio | GCST90315004 | 2.79 |
| 4050 | MED18/TBL1X ratio | GCST90315415 | 2.79 |
| 4051 | GC levels | GCST90162564 | 2.79 |
| 4052 | DTI autoptx L2 ptr l tract | GCST90385185 | 2.78 |
| 4053 | ERBB3/IL1R2 ratio | GCST90314689 | 2.78 |
| 4054 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502396 | 2.78 |
| 4055 | AXIN1/HEXIM1 ratio | GCST90313408 | 2.78 |
| 4056 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 2.78 |
| 4057 | MMP1 levels | GCST90469919 | 2.78 |
| 4058 | GPR37 levels | GCST90469397 | 2.78 |
| 4059 | NECTIN4/SPINK5 ratio | GCST90315534 | 2.78 |
| 4060 | ThalamNuclei lh volume Pf | GCST90002722 | 2.78 |
| 4061 | MNDA/NCF2 ratio | GCST90315472 | 2.78 |
| 4062 | PSIP1 levels | GCST90470354 | 2.77 |
| 4063 | Phospholipids in very large VLDL | GCST90500647 | 2.77 |
| 4064 | IDP T1 SIENAX grey unnormalised volume | GCST90002431 | 2.77 |
| 4065 | Late-onset myasthenia gravis | GCST90093466 | 2.77 |
| 4066 | CPXM1 levels | GCST90468849 | 2.77 |
| 4067 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | GCST90320654 | 2.77 |
| 4068 | FLT4/KDR ratio | GCST90314861 | 2.77 |
| 4069 | FUT8/TNFSF14 ratio | GCST90314895 | 2.77 |
| 4070 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502597 | 2.76 |
| 4071 | CDC37/SNX9 ratio | GCST90313936 | 2.76 |
| 4072 | Omega-3 fatty acids levels | GCST90499139 | 2.76 |
| 4073 | ATP5IF1 levels | GCST90468392 | 2.76 |
| 4074 | Acetoacetate levels (UKB data field 23476) | GCST90269573 | 2.76 |
| 4075 | LRRFIP1 levels | GCST90469805 | 2.76 |
| 4076 | CCN3/COL6A3 ratio | GCST90313720 | 2.76 |
| 4077 | PRSS27 levels | GCST90470342 | 2.76 |
| 4078 | RTN4IP1 levels | GCST90470507 | 2.76 |
| 4079 | IDP dMRI ProbtrackX L2 fmi | GCST90004284 | 2.76 |
| 4080 | ITGB5 levels | GCST90469645 | 2.75 |
| 4081 | TACC3 levels | GCST90470797 | 2.75 |
| 4082 | MMP10 levels | GCST90012050 | 2.75 |
| 4083 | ANXA3/EDAR ratio | GCST90313280 | 2.75 |
| 4084 | CXCL5/PLXNA4 ratio | GCST90314351 | 2.75 |
| 4085 | Cholesteryl esters in small VLDL (UKB data field 23513) | GCST90269610 | 2.74 |
| 4086 | ASS1 levels | GCST90468380 | 2.74 |
| 4087 | Disorders of iris and ciliary body (PheCode 379.5) | GCST90475899 | 2.74 |
| 4088 | CKAP4/TNFRSF4 ratio | GCST90314076 | 2.74 |
| 4089 | Right ventricular peak ejection rate | GCST90268120 | 2.74 |
| 4090 | Red cell distribution width | GCST90002369 | 2.74 |
| 4091 | FADD/NCK2 ratio | GCST90314770 | 2.74 |
| 4092 | BMP4 levels | GCST90468453 | 2.73 |
| 4093 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T225 | ECGA000225 | 2.73 |
| 4094 | CTSO levels | GCST90179277 | 2.73 |
| 4095 | CLMP/PIK3IP1 ratio | GCST90314134 | 2.73 |
| 4096 | PFDN5 levels | GCST90242340 | 2.72 |
| 4097 | CALCB levels | GCST90468529 | 2.72 |
| 4098 | CFD levels | GCST90468725 | 2.72 |
| 4099 | GRAP2/TYMP ratio | GCST90314990 | 2.72 |
| 4100 | Hallux rigidus | FING00000600 | 2.72 |
| 4101 | Blood cell traits latent factor 18 (platelet) | GCST90559260 | 2.71 |
| 4102 | PON1 levels | GCST90470285 | 2.71 |
| 4103 | Cholesteryl ester_18:1_[M+NH4]1+ levels | GCST90060221 | 2.71 |
| 4104 | IDP T1 FAST ROIs L cerebellum VI | GCST90002566 | 2.71 |
| 4105 | RILP levels | GCST90470471 | 2.71 |
| 4106 | MCAM levels | GCST90469870 | 2.71 |
| 4107 | Gamma-CEHC glucuronide levels | GCST90199941 | 2.70 |
| 4108 | Exophthalmic conditions | FING00000526 | 2.70 |
| 4109 | DNM3 levels | GCST90469022 | 2.70 |
| 4110 | IDP T1 FAST ROIs L thalamus | GCST90002547 | 2.70 |
| 4111 | T1 FreeSurfer aseg Left-Lateral-Ventricle | GCST90384139 | 2.70 |
| 4112 | Atrial fibrillation | GCST006414 | 2.70 |
| 4113 | BACH1 levels | GCST90468415 | 2.70 |
| 4114 | ADH4/KRT18 ratio | GCST90313192 | 2.70 |
| 4115 | GPC1/ITGB6 ratio | GCST90314977 | 2.69 |
| 4116 | Excessive, frequent and irregular menstruation | FING00000524 | 2.69 |
| 4117 | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | GCST90004116 | 2.69 |
| 4118 | Phosphatidylcholine-2O_32:0_[M+H]1+ levels | GCST90060244 | 2.69 |
| 4119 | Peripheral enthesopathies and allied syndromes | musculoskeletal | UKBB00000640 | 2.69 |
| 4120 | GP2/LGALS8 ratio | GCST90314961 | 2.69 |
| 4121 | ADGRG2/ITGB1 ratio | GCST90313185 | 2.69 |
| 4122 | TMSB10 levels | GCST90470894 | 2.69 |
| 4123 | Platelet count during postpartum period | GCST90302228 | 2.69 |
| 4124 | SIRPA levels | GCST90470639 | 2.69 |
| 4125 | MMP7 levels | GCST90469921 | 2.69 |
| 4126 | AmygNuclei rh volume Cortical-nucleus | GCST90002664 | 2.68 |
| 4127 | RNF146 levels | GCST90421479 | 2.68 |
| 4128 | CCL26 levels | GCST90468578 | 2.68 |
| 4129 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373 | ECGA000373 | 2.68 |
| 4130 | Retinoschisis and retinal cysts (PheCode 361.2) | GCST90475846 | 2.68 |
| 4131 | Principal component-derived dietary pattern 16 | GCST90133021 | 2.68 |
| 4132 | EDAR/ENO2 ratio | GCST90314574 | 2.68 |
| 4133 | F-chocolate/coffee liking (derived food-liking factor) | GCST90094735 | 2.68 |
| 4134 | SYTL4 levels | GCST90470795 | 2.68 |
| 4135 | INHBC levels | GCST90469615 | 2.68 |
| 4136 | Operation code - anterior/posterior repair bladder/uterus | Operations | UKBB00000548 | 2.68 |
| 4137 | ESM1 levels | GCST90012068 | 2.68 |
| 4138 | IGFBP7 levels | GCST90469532 | 2.68 |
| 4139 | Phospholipids in small VLDL | GCST90499871 | 2.68 |
| 4140 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T444 | ECGA000444 | 2.68 |
| 4141 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditions | UKBB00000100 | 2.67 |
| 4142 | Hyperlipidemia (PheCode 272.1) | GCST90475718 | 2.67 |
| 4143 | TOP1 levels | GCST90470933 | 2.67 |
| 4144 | Nontoxic goitre/thyroid nodule | FING00000887 | 2.67 |
| 4145 | IRAK4/VASH1 ratio | GCST90315201 | 2.67 |
| 4146 | Saturated fatty acids levels | GCST90502659 | 2.67 |
| 4147 | WWP2 levels | GCST90471080 | 2.66 |
| 4148 | T1 FreeSurfer aseg Right-Pallidum | GCST90384164 | 2.66 |
| 4149 | DIABLO/PRKAR1A ratio | GCST90314469 | 2.66 |
| 4150 | CCL5/TFPI ratio | GCST90313708 | 2.66 |
| 4151 | Aspartate aminotransferase levels | GCST90278618 | 2.66 |
| 4152 | Free cholesterol levels in medium VLDL | GCST90092920 | 2.66 |
| 4153 | CAPN3 levels | GCST90468538 | 2.66 |
| 4154 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374 | ECGA000374 | 2.66 |
| 4155 | ENDOU levels | GCST90469107 | 2.66 |
| 4156 | IDP dMRI ProbtrackX ICVF atr l | GCST90004377 | 2.66 |
| 4157 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T435 | ECGA000435 | 2.66 |
| 4158 | PAK4 levels | GCST90470150 | 2.66 |
| 4159 | TNF levels | GCST90470924 | 2.66 |
| 4160 | PGLS levels | GCST90618925 | 2.65 |
| 4161 | Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney disease | GCST90265274 | 2.65 |
| 4162 | LTA levels | GCST90469813 | 2.65 |
| 4163 | Substance use, excluding alcohol | FING00001342 | 2.65 |
| 4164 | EDAR/YES1 ratio | GCST90314594 | 2.65 |
| 4165 | wg lh intensity-contrast medialorbitofrontal | GCST90003805 | 2.65 |
| 4166 | CCL21 levels | GCST90468573 | 2.65 |
| 4167 | TNFRSF13B levels | GCST90470905 | 2.65 |
| 4168 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389 | ECGA000389 | 2.65 |
| 4169 | APBB1IP/POLR2F ratio | GCST90313300 | 2.64 |
| 4170 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8) | GCST90320827 | 2.64 |
| 4171 | Clonal haematopoiesis of indeterminate potential (with or without mosaic chromosomal alteration) | GCST90165267 | 2.64 |
| 4172 | NID2 levels | GCST90470048 | 2.64 |
| 4173 | IDP dMRI TBSS ISOVF Anterior corona radiata R | GCST90004499 | 2.64 |
| 4174 | SNCG levels | GCST90470695 | 2.64 |
| 4175 | Eustachian tube disorders (PheCode 381.2) | GCST90475904 | 2.64 |
| 4176 | Right-hemisphere visual network to amygdala white-matter structural connectivity | GCST90302786 | 2.64 |
| 4177 | MAP2K1 levels | GCST90469851 | 2.64 |
| 4178 | aseg global volume BrainSegNotVent | GCST90002591 | 2.64 |
| 4179 | Tinnitus | GCST90448242 | 2.63 |
| 4180 | Pain (PheCode 338) | GCST90475836 | 2.63 |
| 4181 | CXCL1 levels | GCST90468930 | 2.63 |
| 4182 | Number in household | Household | UKBB00000530 | 2.63 |
| 4183 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488 | ECGU000488 | 2.63 |
| 4184 | IDP dMRI TBSS ICVF Anterior corona radiata L | GCST90004350 | 2.62 |
| 4185 | Omega-3 fatty acids to total fatty acids percentage | GCST90502450 | 2.62 |
| 4186 | IDP dMRI TBSS ICVF Superior corona radiata L | GCST90004352 | 2.62 |
| 4187 | Total fatty acid levels | GCST90502711 | 2.62 |
| 4188 | SELL levels | GCST90470567 | 2.62 |
| 4189 | DEFA1 or DEFA1B levels | GCST90468979 | 2.62 |
| 4190 | ANGPT1/SERPINE1 ratio | GCST90313269 | 2.62 |
| 4191 | Disorders of synovium and tendon | FING00000462 | 2.62 |
| 4192 | Any mental disorder | FING00000100 | 2.61 |
| 4193 | Heel bone mineral density (BMD) (left) | Bone-densitometry of heel | UKBB00000313 | 2.61 |
| 4194 | LY6D/WFDC12 ratio | GCST90315346 | 2.61 |
| 4195 | 1-stearoylglycerophosphoethanolamine levels | GCST90243780 | 2.61 |
| 4196 | Omega-3 fatty acids to total fatty acids percentage | GCST90502449 | 2.61 |
| 4197 | NFATC1 levels | GCST90470033 | 2.61 |
| 4198 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | GCST90475454 | 2.61 |
| 4199 | Plasma homoarginine levels in chronic kidney disease | GCST90265345 | 2.61 |
| 4200 | Omega-6 fatty acids to total fatty acids percentage | GCST90499203 | 2.61 |
| 4201 | CHMP1A levels | GCST90619002 | 2.60 |
| 4202 | CALCOCO1/TJAP1 ratio | GCST90313611 | 2.60 |
| 4203 | T1 FreeSurfer aseg Left-Inf-Lat-Vent | GCST90384140 | 2.60 |
| 4204 | Alkaline phosphatase | Blood biochemistry | UKBB00000027 | 2.60 |
| 4205 | POLR2F levels | GCST90470283 | 2.60 |
| 4206 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T372 | ECGA000372 | 2.60 |
| 4207 | Sarcoidosis | GCST90503483 | 2.59 |
| 4208 | BLMH/SERPINE1 ratio | GCST90313520 | 2.59 |
| 4209 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T377 | ECGU000377 | 2.59 |
| 4210 | EIF4G1/FOXO1 ratio | GCST90314634 | 2.59 |
| 4211 | AZU1/MPO ratio | GCST90313425 | 2.59 |
| 4212 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106 | ECGU000106 | 2.59 |
| 4213 | TNFRSF13B/TNFRSF9 ratio | GCST90315932 | 2.59 |
| 4214 | CLEC1B/NSFL1C ratio | GCST90314099 | 2.59 |
| 4215 | CD46 levels | GCST90468634 | 2.59 |
| 4216 | AXL/IL18BP ratio | GCST90313420 | 2.58 |
| 4217 | Myasthenia gravis | GCST90432156 | 2.58 |
| 4218 | Posterior thigh muscle fat infiltration percentage | GCST90267355 | 2.57 |
| 4219 | PCDH17/PTPRM ratio | GCST90315603 | 2.57 |
| 4220 | EDAR/F2R ratio | GCST90314577 | 2.57 |
| 4221 | Atrial fibrillation (MTAG) | GCST90449054 | 2.57 |
| 4222 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363 | ECGA000363 | 2.57 |
| 4223 | IDP T1 FAST ROIs brain stem | GCST90002561 | 2.57 |
| 4224 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T290 | ECGA000290 | 2.57 |
| 4225 | TACC3/TRIAP1 ratio | GCST90315901 | 2.57 |
| 4226 | DTI TBSS L3 Sagittal stratum L | GCST90384555 | 2.57 |
| 4227 | Total cholesterol levels | GCST90092985 | 2.57 |
| 4228 | FIS1 levels | GCST90469240 | 2.57 |
| 4229 | Left-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302756 | 2.57 |
| 4230 | Reticulocyte count | Blood count | UKBB00000752 | 2.57 |
| 4231 | APOB/APOA1 ratio | GCST90497158 | 2.57 |
| 4232 | Diacylglycerol_34:2_[M+H-H2O]1+ levels | GCST90060178 | 2.56 |
| 4233 | ANGPTL7 levels | GCST90468306 | 2.56 |
| 4234 | Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditions | UKBB00000369 | 2.56 |
| 4235 | Cholesterol in Medium VLDL | GCST90498909 | 2.56 |
| 4236 | rfMRI connectivity (ICA25 edge 101) | GCST90004744 | 2.56 |
| 4237 | PTPN1/SCAMP3 ratio | GCST90315743 | 2.56 |
| 4238 | Gastric ulcer | GCST90270927 | 2.56 |
| 4239 | Cellulitis and abscess of leg, except foot (PheCode 681.5) | GCST90476166 | 2.55 |
| 4240 | MECR levels | GCST90469879 | 2.55 |
| 4241 | Left ventricular wall thickness (mean) | GCST90435264 | 2.55 |
| 4242 | BST1 levels | GCST90468474 | 2.55 |
| 4243 | Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels | GCST90060284 | 2.55 |
| 4244 | Total esterified cholesterol levels | GCST90092986 | 2.55 |
| 4245 | Internal derangement of knee | FING00000684 | 2.55 |
| 4246 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475462 | 2.55 |
| 4247 | CD6 levels | GCST90468644 | 2.54 |
| 4248 | Isolated hypothyroxinemia in pregnancy | GCST90435198 | 2.54 |
| 4249 | MCFD2 levels | GCST90469873 | 2.54 |
| 4250 | HYOU1/TGFBR3 ratio | GCST90315105 | 2.54 |
| 4251 | Cholesteryl ester levels in small VLDL | GCST90092970 | 2.54 |
| 4252 | GLO1 levels | GCST90469358 | 2.54 |
| 4253 | SNAP23/TXLNA ratio | GCST90315857 | 2.53 |
| 4254 | CDH17/SPINT1 ratio | GCST90313944 | 2.53 |
| 4255 | Direct low density lipoprotein levels (UKB data field 30780) | GCST90468080 | 2.53 |
| 4256 | Cream liking | GCST90094746 | 2.53 |
| 4257 | X-21364 levels | GCST90200566 | 2.53 |
| 4258 | Non-cancer illness code, self-reported - depression | Medical conditions | UKBB00000507 | 2.53 |
| 4259 | Facial pigmentation measurement (polar light) | GCST90002284 | 2.53 |
| 4260 | CRADD/SIRT2 ratio | GCST90314243 | 2.53 |
| 4261 | Olsenella C abundance in stool | GCST90032493 | 2.53 |
| 4262 | Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585) | GCST90269682 | 2.53 |
| 4263 | Eosinophil count | GCST90018733 | 2.53 |
| 4264 | Annual healthcare cost | GCST90292604 | 2.53 |
| 4265 | Actinic keratosis | FING00000013 | 2.52 |
| 4266 | GFRA1/SPON2 ratio | GCST90314923 | 2.52 |
| 4267 | Weight | GCST90278650 | 2.52 |
| 4268 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364 | ECGA000364 | 2.52 |
| 4269 | CLSTN2/MATN2 ratio | GCST90314143 | 2.52 |
| 4270 | Resting heart rate | GCST90278636 | 2.52 |
| 4271 | Polyunsaturated fatty acid levels | GCST90502607 | 2.52 |
| 4272 | Risk taking | Mental health | UKBB00000759 | 2.51 |
| 4273 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390 | ECGA000390 | 2.51 |
| 4274 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320944 | 2.51 |
| 4275 | Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heel | UKBB00000318 | 2.51 |
| 4276 | Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heel | UKBB00000324 | 2.51 |
| 4277 | IDP dMRI TBSS MD Posterior thalamic radiation L | GCST90004056 | 2.51 |
| 4278 | MILR1 levels | GCST90469907 | 2.51 |
| 4279 | DOK2/PPP1R12A ratio | GCST90314536 | 2.51 |
| 4280 | CDH17/PECAM1 ratio | GCST90313942 | 2.51 |
| 4281 | IPCEF1/TBCB ratio | GCST90315187 | 2.51 |
| 4282 | Heel bone mineral density (BMD) | Bone-densitometry of heel | UKBB00000315 | 2.50 |
| 4283 | Ground coffee consumption | GCST90132976 | 2.50 |
| 4284 | TNN levels | GCST90470927 | 2.50 |
| 4285 | Fracture of lower leg, including ankle | FING00000555 | 2.50 |
| 4286 | TBL1X levels | GCST90470815 | 2.50 |
| 4287 | CANT1/VSIR ratio | GCST90313621 | 2.50 |
| 4288 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T285 | ECGA000285 | 2.50 |
| 4289 | NRAC levels | GCST90617991 | 2.50 |
| 4290 | PCYT2 levels | GCST90470178 | 2.50 |
| 4291 | COL6A3/CST3 ratio | GCST90314174 | 2.50 |
| 4292 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T308 | ECGU000308 | 2.50 |
| 4293 | eGFR in diabetes mellitus (strict) case-control group (minimal adjustment) | GCST90624781 | 2.50 |
| 4294 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T387 | ECGU000387 | 2.49 |
| 4295 | Psoriasis | GCST90019016 | 2.49 |
| 4296 | Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611) | GCST90269708 | 2.49 |
| 4297 | Secondary thrombocytopenia (PheCode 287.32) | GCST90475810 | 2.49 |
| 4298 | Late-onset myasthenia gravis | GCST90432158 | 2.48 |
| 4299 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320911 | 2.48 |
| 4300 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T226 | ECGA000226 | 2.48 |
| 4301 | Working memory | GCST90503116 | 2.48 |
| 4302 | T1 FreeSurfer a2009s lh S postcentral area | GCST90384734 | 2.48 |
| 4303 | Polyunsaturated fatty acid levels | GCST90502619 | 2.48 |
| 4304 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T439 | ECGA000439 | 2.48 |
| 4305 | DTI autoptx L1 cst l tract | GCST90385147 | 2.48 |
| 4306 | IDP dMRI TBSS L2 Cingulum cingulate gyrus R | GCST90004157 | 2.47 |
| 4307 | Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivity | GCST90302648 | 2.47 |
| 4308 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels | GCST90200060 | 2.47 |
| 4309 | wg lh intensity-contrast rostralmiddlefrontal | GCST90003818 | 2.47 |
| 4310 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391 | ECGA000391 | 2.47 |
| 4311 | DTI TBSS L3 External capsule R | GCST90384556 | 2.46 |
| 4312 | Primary angle-closure glaucoma | FING00001210 | 2.46 |
| 4313 | Hyperthyroidism | GCST90319319 | 2.46 |
| 4314 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | GCST90004362 | 2.46 |
| 4315 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T287 | ECGA000287 | 2.46 |
| 4316 | ITGA6 levels | GCST90469636 | 2.45 |
| 4317 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367 | ECGA000367 | 2.45 |
| 4318 | CD5/TNFRSF9 ratio | GCST90313862 | 2.45 |
| 4319 | PTH levels | GCST90470372 | 2.45 |
| 4320 | F2R/TNFRSF14 ratio | GCST90314739 | 2.45 |
| 4321 | LRRC59 levels | GCST90469804 | 2.45 |
| 4322 | Free cholesterol to total lipids in medium VLDL percentage (UKB data field 23597) | GCST90269694 | 2.45 |
| 4323 | hemoglobin (mean, inv-norm transformed) | GCST90475374 | 2.45 |
| 4324 | Valine levels | GCST90092995 | 2.44 |
| 4325 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T279 | ECGA000279 | 2.44 |
| 4326 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502414 | 2.44 |
| 4327 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133 | ECGU000133 | 2.44 |
| 4328 | IDP T1 FAST ROIs V cerebellum VIIb | GCST90002576 | 2.44 |
| 4329 | PNMA1 levels | GCST90470276 | 2.43 |
| 4330 | Triglycerides in small VLDL | GCST90499915 | 2.43 |
| 4331 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T366 | ECGA000366 | 2.43 |
| 4332 | MAVS/MYO9B ratio | GCST90315390 | 2.43 |
| 4333 | ITGB1BP2/MITD1 ratio | GCST90315214 | 2.43 |
| 4334 | TIE1 levels | GCST90470863 | 2.43 |
| 4335 | Treatment/medication code - amlodipine | Medications | UKBB00000840 | 2.43 |
| 4336 | Clonal haematopoiesis of indeterminate potential (DNMT3A mutation) | GCST90165271 | 2.43 |
| 4337 | F-low caloric food liking (derived food-liking factor) | GCST90094795 | 2.42 |
| 4338 | T1 CAT volume L PlanumPolare | GCST90384086 | 2.42 |
| 4339 | SLC9A3R2 levels | GCST90470666 | 2.42 |
| 4340 | Reticulocyte fraction of red cells | GCST90002406 | 2.42 |
| 4341 | CD58/MEGF10 ratio | GCST90313853 | 2.42 |
| 4342 | Sphingomyelin_36:1_[M+H]1+ levels | GCST90060266 | 2.41 |
| 4343 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T428 | ECGA000428 | 2.41 |
| 4344 | Linoleic acid levels | GCST90498309 | 2.41 |
| 4345 | Transient global amnesia | FING00001374 | 2.41 |
| 4346 | Cholesterol in medium LDL (UKB data field 23540) | GCST90269637 | 2.41 |
| 4347 | DIABLO levels | GCST90468994 | 2.41 |
| 4348 | Treatment/medication code - ventolin 100micrograms inhaler | Medications | UKBB00000860 | 2.41 |
| 4349 | ERBB2 levels | GCST90469139 | 2.40 |
| 4350 | Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivity | GCST90302744 | 2.40 |
| 4351 | GM3 ganglioside (d18:1/24:0) levels | GCST90024729 | 2.40 |
| 4352 | CD58/LTBR ratio | GCST90313851 | 2.40 |
| 4353 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T393 | ECGA000393 | 2.40 |
| 4354 | Lifespan | GCST90551884 | 2.40 |
| 4355 | ATP5IF1/METAP1D ratio | GCST90313391 | 2.40 |
| 4356 | Light-intensity physical activity duration | GCST90061421 | 2.40 |
| 4357 | Triacylglycerol_50:4_[M+NH4]1+ levels | GCST90060466 | 2.40 |
| 4358 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502166 | 2.40 |
| 4359 | IDP dMRI TBSS MO Medial lemniscus L | GCST90003961 | 2.39 |
| 4360 | Degree of unsaturation | GCST90502748 | 2.39 |
| 4361 | Time spent using computer | Physical activity | UKBB00000820 | 2.39 |
| 4362 | RLN2 levels | GCST90470474 | 2.39 |
| 4363 | IDP dMRI TBSS L2 Genu of corpus callosum | GCST90004125 | 2.39 |
| 4364 | JCHAIN levels | GCST90469661 | 2.39 |
| 4365 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502593 | 2.39 |
| 4366 | IDP dMRI TBSS MD Posterior thalamic radiation R | GCST90004055 | 2.38 |
| 4367 | Heart valve disorders (PheCode 395) | GCST90475913 | 2.38 |
| 4368 | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | GCST90004115 | 2.38 |
| 4369 | RNF5 levels | GCST90470488 | 2.38 |
| 4370 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus R | GCST90004367 | 2.38 |
| 4371 | Omega-3 fatty acids to total fatty acids percentage | GCST90502466 | 2.38 |
| 4372 | Temporomandibular joint disorders | FING00001354 | 2.38 |
| 4373 | IDP dMRI ProbtrackX ISOVF atr l | GCST90004527 | 2.38 |
| 4374 | Other and unspecified anaemias | FING00000925 | 2.38 |
| 4375 | EDAR/EGF ratio | GCST90314573 | 2.38 |
| 4376 | Cardiorespiratory fitness (vo2 max) | GCST90093316 | 2.38 |
| 4377 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T431 | ECGA000431 | 2.38 |
| 4378 | TDRKH levels | GCST90470827 | 2.38 |
| 4379 | Other predominantly sexually transmitted diseases, not elsewhere classified | FING00001089 | 2.37 |
| 4380 | LMOD1 levels | GCST90469783 | 2.37 |
| 4381 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T442 | ECGA000442 | 2.37 |
| 4382 | Operation code - tonsillectomy +/- adenoids | Operations | UKBB00000567 | 2.37 |
| 4383 | AmygNuclei rh volume Whole-amygdala | GCST90002667 | 2.37 |
| 4384 | BCAM/CLEC14A ratio | GCST90313470 | 2.37 |
| 4385 | CD177 levels | GCST90468603 | 2.37 |
| 4386 | Systolic blood pressure, manual reading | Blood pressure | UKBB00000810 | 2.37 |
| 4387 | Concentration of medium LDL particles (UKB data field 23537) | GCST90269634 | 2.37 |
| 4388 | Sleep apnoea, including avohilmo | FING00001310 | 2.36 |
| 4389 | Thyroid cancer (PheCode 193) | GCST90475600 | 2.36 |
| 4390 | Physical activity (confirmatory factor analysis Factor 23) | GCST90309357 | 2.36 |
| 4391 | CD109 levels | GCST90468597 | 2.36 |
| 4392 | eGFR in diabetes mellitus (loose) case-control group (minimal adjustment) | GCST90624790 | 2.36 |
| 4393 | SDC4/SELP ratio | GCST90315817 | 2.36 |
| 4394 | CA1/HMBS ratio | GCST90313573 | 2.36 |
| 4395 | CD28 levels | GCST90468616 | 2.36 |
| 4396 | Lymphocyte count | Blood count | UKBB00000411 | 2.36 |
| 4397 | APOB/APOA1 ratio | GCST90269538 | 2.36 |
| 4398 | FKBP4/SIRT2 ratio | GCST90314841 | 2.36 |
| 4399 | C1RL levels | GCST90468492 | 2.36 |
| 4400 | IDP dMRI ProbtrackX ICVF ml l | GCST90004392 | 2.36 |
| 4401 | TNFRSF13C levels | GCST90470906 | 2.35 |
| 4402 | Number of diet questionnaires completed | Diet questionnaire performance | UKBB00000536 | 2.35 |
| 4403 | ESR1 levels | GCST90469155 | 2.35 |
| 4404 | DLK1 levels | GCST90469003 | 2.35 |
| 4405 | EDAR/PRDX5 ratio | GCST90314583 | 2.35 |
| 4406 | Abnormal movement (PheCode 350) | GCST90475840 | 2.35 |
| 4407 | CALCOCO1/CRACR2A ratio | GCST90313598 | 2.35 |
| 4408 | DNAJA2/SCAMP3 ratio | GCST90314507 | 2.35 |
| 4409 | LEG1 levels | GCST90469753 | 2.35 |
| 4410 | Linoleic acid to total fatty acids percentage | GCST90502333 | 2.35 |
| 4411 | Free cholesterol in small VLDL (UKB data field 23514) | GCST90269611 | 2.35 |
| 4412 | TPSAB1 levels | GCST90470951 | 2.34 |
| 4413 | Principal component-derived dietary pattern 13 | GCST90133018 | 2.34 |
| 4414 | REG1B levels | GCST90470448 | 2.34 |
| 4415 | Rheumatoid arthritis | GCST90018690 | 2.34 |
| 4416 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87) | GCST90320906 | 2.34 |
| 4417 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371 | ECGA000371 | 2.34 |
| 4418 | PLXNA4 levels | GCST90470265 | 2.34 |
| 4419 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T365 | ECGA000365 | 2.34 |
| 4420 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T288 | ECGU000288 | 2.34 |
| 4421 | Cholesterol in small VLDL (UKB data field 23512) | GCST90269609 | 2.34 |
| 4422 | Reticulocyte count (UKB data field 30250) | GCST90468100 | 2.34 |
| 4423 | aparc-Desikan lh volume supramarginal | GCST90002798 | 2.34 |
| 4424 | PPIF levels | GCST90470293 | 2.33 |
| 4425 | Other and unspecified rosacea | FING00000951 | 2.33 |
| 4426 | IL5RA levels | GCST90469600 | 2.33 |
| 4427 | ARHGEF12/IRAK4 ratio | GCST90313350 | 2.33 |
| 4428 | Birth weight | Early life factors | UKBB00000095 | 2.33 |
| 4429 | AGRP/NPY ratio | GCST90313203 | 2.33 |
| 4430 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T429 | ECGA000429 | 2.33 |
| 4431 | CD70 levels | GCST90468645 | 2.33 |
| 4432 | AKT1S1/FHIT ratio | GCST90313228 | 2.33 |
| 4433 | Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588) | GCST90269685 | 2.33 |
| 4434 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T434 | ECGA000434 | 2.33 |
| 4435 | FST levels | GCST90469273 | 2.33 |
| 4436 | Lymphocyte count | GCST90025984 | 2.33 |
| 4437 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T218 | ECGA000218 | 2.32 |
| 4438 | Thyroxine levels | GCST90200293 | 2.32 |
| 4439 | JAM2/TNFRSF21 ratio | GCST90315242 | 2.32 |
| 4440 | Plasma glycocholenate sulfate* levels in chronic kidney disease | GCST90265291 | 2.32 |
| 4441 | Mean corpuscular volume | GCST90002335 | 2.32 |
| 4442 | CACNA2D3 levels | GCST90243348 | 2.32 |
| 4443 | THOP1 levels | GCST90470856 | 2.32 |
| 4444 | IDP dMRI TBSS FA Sagittal stratum R | GCST90003907 | 2.31 |
| 4445 | SNX15 levels | GCST90470699 | 2.31 |
| 4446 | Plasma N-acetylhistidine levels in chronic kidney disease | GCST90265576 | 2.31 |
| 4447 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T307 | ECGU000307 | 2.31 |
| 4448 | HPSE levels | GCST90469473 | 2.31 |
| 4449 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule R | GCST90004191 | 2.31 |
| 4450 | DTI TBSS MD Genu of corpus callosum | GCST90384574 | 2.31 |
| 4451 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T146 | ECGU000146 | 2.31 |
| 4452 | Eczema | GCST90468126 | 2.31 |
| 4453 | TIMP1 levels | GCST90470869 | 2.31 |
| 4454 | Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heel | UKBB00000322 | 2.31 |
| 4455 | Reticulocyte percentage | Blood count | UKBB00000753 | 2.31 |
| 4456 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362 | ECGA000362 | 2.30 |
| 4457 | Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heel | UKBB00000316 | 2.30 |
| 4458 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T432 | ECGA000432 | 2.30 |
| 4459 | CXCL11 levels | GCST90274781 | 2.30 |
| 4460 | Left ventricular mass (indexed to body surface area) | GCST90435260 | 2.30 |
| 4461 | Degree of unsaturation | GCST90502752 | 2.30 |
| 4462 | Sphingomyelin_34:0_[M+H]1+ levels | GCST90060241 | 2.30 |
| 4463 | FUT8/PDGFA ratio | GCST90314890 | 2.30 |
| 4464 | DNA methylation-estimated granulocyte proportions | GCST90014287 | 2.29 |
| 4465 | MMP12 levels | GCST90012070 | 2.29 |
| 4466 | IDP dMRI ProbtrackX ICVF slf l | GCST90004396 | 2.29 |
| 4467 | IDP dMRI ProbtrackX L3 ifo r | GCST90004313 | 2.29 |
| 4468 | TIA1 levels | GCST90470862 | 2.29 |
| 4469 | CSNK2A1 levels | GCST90468889 | 2.29 |
| 4470 | DTI TBSS L3 Superior fronto-occipital fasciculus R | GCST90384566 | 2.29 |
| 4471 | Left-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302771 | 2.29 |
| 4472 | HMBS/PKLR ratio | GCST90315063 | 2.29 |
| 4473 | Volume of left medial nucleus | GCST90474892 | 2.29 |
| 4474 | Triacylglycerol_58:7_[M+NH4]1+ levels | GCST90060564 | 2.29 |
| 4475 | S100A4 levels | GCST90470518 | 2.29 |
| 4476 | CRKL/FIS1 ratio | GCST90314266 | 2.29 |
| 4477 | DTI autoptx L3 str r tract | GCST90385217 | 2.28 |
| 4478 | Maximum digits remembered correctly | Numeric memory | UKBB00000430 | 2.28 |
| 4479 | aparc-a2009s rh area G+S-subcentral | GCST90003374 | 2.28 |
| 4480 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392 | ECGA000392 | 2.28 |
| 4481 | Cholesteryl esters in VLDL (UKB data field 23416) | GCST90269513 | 2.28 |
| 4482 | Cerebral aneurysm | GCST90018595 | 2.28 |
| 4483 | Duodenal ulcer | GCST90270928 | 2.28 |
| 4484 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368 | ECGA000368 | 2.28 |
| 4485 | Fracture of lumbar spine and pelvis | FING00000556 | 2.27 |
| 4486 | IGF1 levels | GCST90468078 | 2.27 |
| 4487 | CLPS/PRSS2 ratio | GCST90314141 | 2.27 |
| 4488 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T90 | ECGA000090 | 2.27 |
| 4489 | INSR levels | GCST90469623 | 2.26 |
| 4490 | Medication use (antiglaucoma preparations and miotics) | GCST90018782 | 2.26 |
| 4491 | GAL levels | GCST90469300 | 2.26 |
| 4492 | SUGT1 levels | GCST90470780 | 2.26 |
| 4493 | Atrial fibrillation/atrial flutter | GCST90018576 | 2.26 |
| 4494 | APOH levels | GCST90468340 | 2.26 |
| 4495 | CD69/PLXNB3 ratio | GCST90313881 | 2.25 |
| 4496 | CPXM1/HBEGF ratio | GCST90314219 | 2.25 |
| 4497 | IDP dMRI TBSS L1 Body of corpus callosum | GCST90004078 | 2.25 |
| 4498 | ADGRB3 levels | GCST90468234 | 2.25 |
| 4499 | PPP1R12A/VEGFC ratio | GCST90315715 | 2.25 |
| 4500 | RNF149 levels | GCST90470482 | 2.25 |
| 4501 | Early age-related macular degeneration | GCST010723 | 2.25 |
| 4502 | PDLIM7/PLA2G4A ratio | GCST90315637 | 2.25 |
| 4503 | THBD levels | GCST90012048 | 2.25 |
| 4504 | PSME2/RBKS ratio | GCST90315737 | 2.25 |
| 4505 | SESTD1 levels | GCST90470604 | 2.25 |
| 4506 | CNTN3/NCS1 ratio | GCST90314165 | 2.25 |
| 4507 | Urine dimethylglycine levels in chronic kidney disease | GCST90265045 | 2.24 |
| 4508 | Neoplasm of uncertain behavior of skin (PheCode 173) | GCST90475585 | 2.24 |
| 4509 | rfMRI connectivity (ICA100 edge 387) | GCST90005240 | 2.24 |
| 4510 | Familial combined hyperlipidemia defined by Consensus criteria | GCST90104006 | 2.24 |
| 4511 | GFRA3/LAYN ratio | GCST90314926 | 2.24 |
| 4512 | SRSF7 levels | GCST90242771 | 2.24 |
| 4513 | Glomerular filtration rate (creatinine) | GCST003372 | 2.23 |
| 4514 | Medication use (HMG CoA reductase inhibitors) | GCST90018769 | 2.23 |
| 4515 | IDP dMRI TBSS FA Genu of corpus callosum | GCST90003879 | 2.23 |
| 4516 | Biological Sibling: Coronary Artery / Coronary Heart Disease | GCST90476370 | 2.23 |
| 4517 | SUSD1 levels | GCST90470786 | 2.23 |
| 4518 | RP2 levels | GCST90470493 | 2.23 |
| 4519 | ICD10 O12: Gestational oedema and proteinuria without hypertension | GCST90454231 | 2.23 |
| 4520 | CCL16 levels | GCST90468568 | 2.23 |
| 4521 | DKK4 levels | GCST90468999 | 2.22 |
| 4522 | Carnitine levels | GCST90243481 | 2.22 |
| 4523 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T430 | ECGA000430 | 2.22 |
| 4524 | Cholesterol in Small VLDL | GCST90499750 | 2.22 |
| 4525 | Linoleic acid levels | GCST90502307 | 2.22 |
| 4526 | ANXA3 levels | GCST90468318 | 2.22 |
| 4527 | IDP dMRI TBSS L2 Posterior limb of internal capsule L | GCST90004142 | 2.22 |
| 4528 | wg rh intensity-contrast middletemporal | GCST90003841 | 2.22 |
| 4529 | Omega-3 fatty acids to total fatty acids percentage | GCST90502448 | 2.21 |
| 4530 | Free cholesterol to total lipids ratio in small LDL | GCST90092961 | 2.21 |
| 4531 | NADK levels | GCST90469993 | 2.21 |
| 4532 | Reticulocyte percentage (UKB data field 30240) | GCST90468101 | 2.20 |
| 4533 | APRT/PSME1 ratio | GCST90313338 | 2.20 |
| 4534 | PAEP levels | GCST90470144 | 2.20 |
| 4535 | Spermatocele | FING00001319 | 2.20 |
| 4536 | CCL4 levels | GCST90012052 | 2.20 |
| 4537 | DTI TBSS L1 Anterior corona radiata L | GCST90384451 | 2.19 |
| 4538 | SH2B3/SUGT1 ratio | GCST90315840 | 2.19 |
| 4539 | Macular degeneration (senile) of retina NOS (PheCode 362.29) | GCST90475857 | 2.19 |
| 4540 | PLAUR/PRSS8 ratio | GCST90315675 | 2.19 |
| 4541 | Total free cholesterol levels (UKB data field 23419) | GCST90269516 | 2.19 |
| 4542 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T443 | ECGA000443 | 2.19 |
| 4543 | IGF1 levels | UKBB00000337 | 2.19 |
| 4544 | GMFG levels | GCST90469366 | 2.18 |
| 4545 | Average diameter for LDL particles | GCST90092889 | 2.18 |
| 4546 | PLIN1 levels | GCST90470258 | 2.18 |
| 4547 | Deep endometriosis | FING00000382 | 2.18 |
| 4548 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T376 | ECGU000376 | 2.18 |
| 4549 | F2R levels | GCST90469168 | 2.18 |
| 4550 | Feeling worry | GCST006950 | 2.18 |
| 4551 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T287 | ECGU000287 | 2.18 |
| 4552 | RABGAP1L levels | GCST90470416 | 2.18 |
| 4553 | Free cholesterol in medium VLDL | GCST90498960 | 2.18 |
| 4554 | ITGAL levels | GCST90469637 | 2.18 |
| 4555 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T280 | ECGA000280 | 2.18 |
| 4556 | DECR1/MAP2K6 ratio | GCST90314447 | 2.17 |
| 4557 | PSRC1/SMAD1 ratio | GCST90315741 | 2.17 |
| 4558 | CCL25 levels | GCST90468577 | 2.17 |
| 4559 | CAG-177 abundance in stool | GCST90032261 | 2.17 |
| 4560 | CDKN1A/TBL1X ratio | GCST90313977 | 2.17 |
| 4561 | IDP dMRI TBSS L2 Posterior thalamic radiation L | GCST90004152 | 2.17 |
| 4562 | F2R/GP6 ratio | GCST90314730 | 2.17 |
| 4563 | IDP T1 FAST ROIs R cerebellum IX | GCST90002586 | 2.17 |
| 4564 | Free cholesterol to total lipids in small HDL percentage (UKB data field 23647) | GCST90269744 | 2.16 |
| 4565 | SLC39A14 levels | GCST90470660 | 2.16 |
| 4566 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T433 | ECGA000433 | 2.16 |
| 4567 | ANGPTL3/TFPI ratio | GCST90313270 | 2.16 |
| 4568 | Usual walking pace | Physical activity | UKBB00000891 | 2.16 |
| 4569 | F2R levels | GCST90012010 | 2.16 |
| 4570 | C1QTNF1 levels | GCST90468488 | 2.16 |
| 4571 | FLRT2 levels | GCST90469248 | 2.16 |
| 4572 | FKBP5/ZBTB16 ratio | GCST90314850 | 2.16 |
| 4573 | Propionylglycine levels | GCST90199705 | 2.16 |
| 4574 | Triglycerides in medium VLDL | GCST90499064 | 2.15 |
| 4575 | Left ventricular end systole inferolateral wall thickness | GCST90278510 | 2.15 |
| 4576 | PPP1R2/TACC3 ratio | GCST90315719 | 2.15 |
| 4577 | Phospholipids in medium LDL (UKB data field 23539) | GCST90269636 | 2.14 |
| 4578 | Omega-3 fatty acids levels | GCST90499145 | 2.14 |
| 4579 | Dementia due to Parkinson's disease (more control exclusions) | FING00000392 | 2.14 |
| 4580 | DCXR/SCLY ratio | GCST90314440 | 2.14 |
| 4581 | Phenylalanine levels (UKB data field 23468) | GCST90269565 | 2.14 |
| 4582 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T306 | ECGU000306 | 2.14 |
| 4583 | Status post-ami | FING00001333 | 2.13 |
| 4584 | Testosterone | Blood biochemistry | UKBB00000816 | 2.13 |
| 4585 | MAVS/MZT1 ratio | GCST90315391 | 2.13 |
| 4586 | ZNF830 levels | GCST90471102 | 2.13 |
| 4587 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71) | GCST90320634 | 2.13 |
| 4588 | Biological Sibling: Asthma | GCST90476372 | 2.13 |
| 4589 | Fasciitis (PheCode 728.7) | GCST90476244 | 2.13 |
| 4590 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T375 | ECGU000375 | 2.13 |
| 4591 | MSLN levels | GCST90469948 | 2.12 |
| 4592 | eosinophil (absolute count, minimum, inv-norm transformed) | GCST90475294 | 2.12 |
| 4593 | Phospholipid levels in very small VLDL | GCST90093036 | 2.12 |
| 4594 | C5 levels | GCST90468500 | 2.12 |
| 4595 | ITGB1BP2/WASF1 ratio | GCST90315224 | 2.12 |
| 4596 | Familial combined hyperlipidemia defined by Mexico criteria | GCST90104007 | 2.12 |
| 4597 | T1 FreeSurfer a2009s rh S temporal sup volume | GCST90385110 | 2.12 |
| 4598 | STK24 levels | GCST90470766 | 2.12 |
| 4599 | X-24544 levels | GCST90200636 | 2.11 |
| 4600 | T1 CAT volume R InsularCortex | GCST90384003 | 2.11 |
| 4601 | NFATC1/SPRY2 ratio | GCST90315539 | 2.11 |
| 4602 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90501042 | 2.11 |
| 4603 | Basophil count | GCST90002293 | 2.11 |
| 4604 | AXIN1/CALCOCO1 ratio | GCST90313402 | 2.11 |
| 4605 | LRP11/ROR1 ratio | GCST90315330 | 2.11 |
| 4606 | Medication use (drugs affecting bone structure and mineralization) | GCST90018773 | 2.10 |
| 4607 | CIAPIN1/PLA2G4A ratio | GCST90314065 | 2.10 |
| 4608 | RNF41/WWP2 ratio | GCST90315782 | 2.10 |
| 4609 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 2.10 |
| 4610 | DTI TBSS L3 Superior longitudinal fasciculus L | GCST90384565 | 2.10 |
| 4611 | X-21467 levels | GCST90200594 | 2.10 |
| 4612 | wg rh intensity-contrast insula | GCST90003861 | 2.10 |
| 4613 | GRAP2/PPP1R2 ratio | GCST90314985 | 2.10 |
| 4614 | Subjective well-being | GCST90104897 | 2.10 |
| 4615 | EGLN1 levels | GCST90469087 | 2.10 |
| 4616 | Malignant melanoma, excluding all cancers (controls excluding all cancers) | FING00000750 | 2.10 |
| 4617 | Charcot foot | FING00000268 | 2.10 |
| 4618 | Urine N1,N12-diacetylspermine levels in chronic kidney disease | GCST90265683 | 2.10 |
| 4619 | DKK1/PPCDC ratio | GCST90314477 | 2.09 |
| 4620 | SPOCK2 levels | GCST90242987 | 2.09 |
| 4621 | CDH17/PTPRM ratio | GCST90313943 | 2.09 |
| 4622 | Processed meat intake | Diet | UKBB00000711 | 2.09 |
| 4623 | Volume of right cortical nucleus | GCST90475033 | 2.09 |
| 4624 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142 | ECGU000142 | 2.09 |
| 4625 | DTI autoptx MD unc l tract | GCST90385245 | 2.09 |
| 4626 | TNFRSF10A levels | GCST90470899 | 2.09 |
| 4627 | Inguinal hernia | GCST90018648 | 2.09 |
| 4628 | PCDH17/ROBO1 ratio | GCST90315604 | 2.08 |
| 4629 | Triglycerides to total lipids in large LDL percentage (UKB data field 23618) | GCST90269715 | 2.08 |
| 4630 | Average diameter for LDL particles (UKB data field 23432) | GCST90269529 | 2.08 |
| 4631 | rfMRI amplitudes (ICA100 node 44) | GCST90004632 | 2.08 |
| 4632 | NID1/TIMP3 ratio | GCST90315543 | 2.08 |
| 4633 | RGMB/THY1 ratio | GCST90315771 | 2.08 |
| 4634 | ALPI levels | GCST90468285 | 2.08 |
| 4635 | Paradoxical eczema in biologic-treated plaque psoriasis | GCST90162550 | 2.08 |
| 4636 | Pollen allergy | FING00001176 | 2.07 |
| 4637 | IDP T1 FIRST right putamen volume | GCST90002441 | 2.07 |
| 4638 | Urinary tryptophan to urinary creatinine ratio | GCST90451748 | 2.07 |
| 4639 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T220 | ECGA000220 | 2.07 |
| 4640 | Angina pectoris | GCST90018573 | 2.07 |
| 4641 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320883 | 2.06 |
| 4642 | Blood cell traits latent factor 13 (red cell) | GCST90559255 | 2.06 |
| 4643 | Hair colour (natural, before greying) - Light brown | Sun exposure | UKBB00000298 | 2.06 |
| 4644 | GNLY/GZMA ratio | GCST90314949 | 2.06 |
| 4645 | Diacylglycerol (18:0_18:1) levels | GCST90024714 | 2.05 |
| 4646 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T286 | ECGA000286 | 2.05 |
| 4647 | TNXB levels | GCST90470930 | 2.05 |
| 4648 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T427 | ECGA000427 | 2.05 |
| 4649 | wg lh intensity-contrast parsopercularis | GCST90003809 | 2.05 |
| 4650 | PDCD6IP levels | GCST90618969 | 2.05 |
| 4651 | X-17676 levels | GCST90200548 | 2.05 |
| 4652 | CBLN4/RET ratio | GCST90313660 | 2.05 |
| 4653 | wg rh intensity-contrast transversetemporal | GCST90003860 | 2.05 |
| 4654 | Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9) | GCST90475908 | 2.04 |
| 4655 | HTRA2/TRIAP1 ratio | GCST90315099 | 2.04 |
| 4656 | CIAPIN1/VEGFC ratio | GCST90314071 | 2.04 |
| 4657 | LYN levels | GCST90469826 | 2.04 |
| 4658 | Anterior thigh muscle fat infiltration percentage | GCST90267351 | 2.04 |
| 4659 | PDGFA/VEGFC ratio | GCST90315622 | 2.04 |
| 4660 | Psoriasis | FING00001222 | 2.04 |
| 4661 | Acute appendicitis | FING00000017 | 2.04 |
| 4662 | IL18RAP levels | GCST90469566 | 2.04 |
| 4663 | Sporadic miscarriage | GCST011888 | 2.04 |
| 4664 | SYT1 levels | GCST90470794 | 2.04 |
| 4665 | PPP1R12A/SKAP2 ratio | GCST90315710 | 2.03 |
| 4666 | Milk type used: Full cream (UKB data field 1418_1) | GCST90132938 | 2.03 |
| 4667 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 2.03 |
| 4668 | EBAG9/TBCB ratio | GCST90314567 | 2.03 |
| 4669 | FETUB levels | GCST90469215 | 2.03 |
| 4670 | Cholesteryl ester levels in VLDL | GCST90092997 | 2.03 |
| 4671 | SCARA5/TGFBI ratio | GCST90315809 | 2.03 |
| 4672 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T394 | ECGA000394 | 2.03 |
| 4673 | wg lh intensity-contrast lingual | GCST90003804 | 2.03 |
| 4674 | CD40/TIMP3 ratio | GCST90313829 | 2.03 |
| 4675 | Appendectomy | FING00000104 | 2.02 |
| 4676 | Allergy/adverse effect of penicillin | injuries & poisonings | UKBB00000028 | 2.02 |
| 4677 | Epilepsy | FING00000511 | 2.02 |
| 4678 | EDAR/TREML2 ratio | GCST90314592 | 2.02 |
| 4679 | MPHOSPH8/USP8 ratio | GCST90315479 | 2.02 |
| 4680 | Peptic ulcer disease | GCST90270926 | 2.02 |
| 4681 | SLAMF1 levels | GCST90470649 | 2.01 |
| 4682 | DLK1/FAP ratio | GCST90314491 | 2.01 |
| 4683 | PDGFB levels | GCST90470189 | 2.01 |
| 4684 | INPP1/NT5C3A ratio | GCST90315177 | 2.01 |
| 4685 | IL22 levels | GCST90088066 | 2.01 |
| 4686 | AMBP/HAVCR1 ratio | GCST90313254 | 2.01 |
| 4687 | QPCT levels | GCST90470401 | 2.01 |
| 4688 | LAIR1 levels | GCST90469728 | 2.01 |
| 4689 | Concentration of small LDL particles | GCST90092963 | 2.01 |
| 4690 | IDP T1 FAST ROIs R subcallosal cortex | GCST90002504 | 2.01 |
| 4691 | Triglycerides in medium LDL | GCST90498864 | 2.01 |
| 4692 | Cholesterol to total lipids in IDL percentage (UKB data field 23610) | GCST90269707 | 2.01 |
| 4693 | Operation code - inguinal hernia repair | Operations | UKBB00000560 | 2.01 |
| 4694 | Neurociticism | GCST006940 | 2.01 |
| 4695 | SCGB3A2 levels | GCST90470543 | 2.01 |
| 4696 | Anxiety, nerves or generalized anxiety disorder | Mental distress | UKBB00000039 | 2.01 |
| 4697 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 2.00 |
| 4698 | Cerebrospinal fluid 5-methylthioadenosine (MTA) levels | GCST90318216 | 2.00 |
| 4699 | BECN1 levels | GCST90468438 | 2.00 |
| 4700 | DTI TBSS L2 Sagittal stratum L | GCST90384507 | 2.00 |
| 4701 | Triglycerides in large VLDL | GCST90498280 | 2.00 |
| 4702 | DTI autoptx FA slf r tract | GCST90385134 | 2.00 |
| 4703 | BA-exvivo rh area BA3b | GCST90003224 | 2.00 |
| 4704 | Abnormal findings examination of lungs (PheCode 514) | GCST90476043 | 2.00 |
| 4705 | OBP2B levels | GCST90470113 | 2.00 |
| 4706 | CXCL12 levels | GCST90468925 | 2.00 |
| 4707 | DTI TBSS FA Superior longitudinal fasciculus R | GCST90384420 | 1.99 |
| 4708 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T426 | ECGA000426 | 1.99 |
| 4709 | T1 FreeSurfer DK rh lingual area | GCST90385701 | 1.99 |
| 4710 | Liver enzyme levels (alanine transaminase) | GCST90013405 | 1.99 |
| 4711 | Feeling miserable | GCST006943 | 1.99 |
| 4712 | CD244/EDAR ratio | GCST90313764 | 1.99 |
| 4713 | Recent feelings of tiredness or low energy | Depression | UKBB00000740 | 1.99 |
| 4714 | Red blood cell count | GCST90002364 | 1.99 |
| 4715 | wg rh intensity-contrast isthmuscingulate | GCST90003836 | 1.99 |
| 4716 | FCRL5/LY96 ratio | GCST90314803 | 1.99 |
| 4717 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T100 | ECGU000100 | 1.98 |
| 4718 | IDP dMRI ProbtrackX L3 ptr r | GCST90004320 | 1.98 |
| 4719 | MPIG6B levels | GCST90469935 | 1.98 |
| 4720 | SCARF1/TNFRSF14 ratio | GCST90315812 | 1.98 |
| 4721 | TRIM58 levels | GCST90470969 | 1.98 |
| 4722 | Hypertrophy of breast in women and men | FING00000645 | 1.97 |
| 4723 | Cholesterol levels in small VLDL | GCST90092968 | 1.97 |
| 4724 | ANXA4 levels | GCST90468319 | 1.97 |
| 4725 | RTBDN levels | GCST90470505 | 1.97 |
| 4726 | ITPA levels | GCST90469654 | 1.97 |
| 4727 | lymphocyte (absolute count, maximum, inv-norm transformed) | GCST90475423 | 1.96 |
| 4728 | CHRDL1/SMOC2 ratio | GCST90314062 | 1.96 |
| 4729 | Total free cholesterol levels | GCST90092988 | 1.96 |
| 4730 | ThalamNuclei lh volume PuA | GCST90002720 | 1.96 |
| 4731 | CLEC11A levels | GCST90468764 | 1.96 |
| 4732 | SNAP23 levels | GCST90470690 | 1.95 |
| 4733 | Saturated fatty acids to total fatty acids percentage (UKB data field 23455) | GCST90269552 | 1.95 |
| 4734 | CDSN/KLK8 ratio | GCST90313996 | 1.95 |
| 4735 | OSMR levels | GCST90470132 | 1.95 |
| 4736 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475350 | 1.95 |
| 4737 | MAP2 levels | GCST90469853 | 1.95 |
| 4738 | Abnormalities of forces of labour | FING00000003 | 1.95 |
| 4739 | Total testosterone levels | GCST90503313 | 1.95 |
| 4740 | CD69/EDAR ratio | GCST90313875 | 1.95 |
| 4741 | Hyperglyceridemia (PheCode 272.12) | GCST90475724 | 1.94 |
| 4742 | BAP18 levels | GCST90468422 | 1.94 |
| 4743 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T448 | ECGA000448 | 1.94 |
| 4744 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T440 | ECGA000440 | 1.94 |
| 4745 | Rheumatoid arthritis | GCST90132224 | 1.93 |
| 4746 | FKBP5 levels | GCST90469244 | 1.93 |
| 4747 | MMP1/MMP3 ratio | GCST90315461 | 1.93 |
| 4748 | Volume of right paralaminar nucleus | GCST90474928 | 1.93 |
| 4749 | Breast cancer (estrogen-receptor negative) | GCST005076 | 1.93 |
| 4750 | Wet age-related macular degeneration | FING00001448 | 1.93 |
| 4751 | IDP dMRI ProbtrackX ICVF unc r | GCST90004401 | 1.93 |
| 4752 | PRG3 levels | GCST90470323 | 1.93 |
| 4753 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369 | ECGA000369 | 1.93 |
| 4754 | Mean platelet volume during first trimester of pregnancy | GCST90302229 | 1.93 |
| 4755 | Total testosterone levels | GCST90012113 | 1.93 |
| 4756 | F-healthy breakfast food liking (derived food-liking factor) | GCST90094780 | 1.93 |
| 4757 | ACADSB levels | GCST90468195 | 1.93 |
| 4758 | Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels | GCST90060243 | 1.92 |
| 4759 | Left ventricular stroke volume | GCST90268130 | 1.92 |
| 4760 | Other disorders of eye and adnexa | FING00001025 | 1.92 |
| 4761 | LTBP3 levels | GCST90469815 | 1.92 |
| 4762 | ITGB1/NCAM1 ratio | GCST90315227 | 1.92 |
| 4763 | Cauliflower liking | GCST90094727 | 1.92 |
| 4764 | BBQ/grilled meat liking | GCST90094698 | 1.92 |
| 4765 | IDP T1 FIRST left putamen volume | GCST90002440 | 1.92 |
| 4766 | Free cholesterol to total lipids in small LDL percentage (UKB data field 23627) | GCST90269724 | 1.92 |
| 4767 | RHOC levels | GCST90470467 | 1.92 |
| 4768 | POF1B levels | GCST90470281 | 1.92 |
| 4769 | HLA-DQA2 levels | GCST90427049 | 1.92 |
| 4770 | Volume of left lateral nucleus | GCST90474973 | 1.92 |
| 4771 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 1.92 |
| 4772 | CD69/CDKN2D ratio | GCST90313866 | 1.92 |
| 4773 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282 | ECGA000282 | 1.91 |
| 4774 | CCL20 levels | GCST90012077 | 1.91 |
| 4775 | Volume of left paralaminar nucleus | GCST90474985 | 1.91 |
| 4776 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T92 | ECGA000092 | 1.91 |
| 4777 | CD40 levels | GCST90468633 | 1.91 |
| 4778 | PNLIPRP2 levels | GCST90470274 | 1.91 |
| 4779 | CXCL11/VTA1 ratio | GCST90314337 | 1.91 |
| 4780 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320635 | 1.91 |
| 4781 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370 | ECGA000370 | 1.91 |
| 4782 | SLITRK1 levels | GCST90470669 | 1.91 |
| 4783 | WASL levels | GCST90471070 | 1.91 |
| 4784 | HLA-A levels | GCST90469457 | 1.91 |
| 4785 | TNFRSF4/TNFRSF8 ratio | GCST90315938 | 1.91 |
| 4786 | GP1BA/HBEGF ratio | GCST90314956 | 1.90 |
| 4787 | Horseradish liking | GCST90094783 | 1.90 |
| 4788 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T441 | ECGA000441 | 1.90 |
| 4789 | Other disorders of circulatory system | circulatory system | UKBB00000607 | 1.90 |
| 4790 | CLEC1B/HEXIM1 ratio | GCST90314093 | 1.90 |
| 4791 | 5alpha-androstan-3beta,17beta-diol monosulfate (2) levels | GCST90199855 | 1.90 |
| 4792 | Beef/steak liking | GCST90094700 | 1.90 |
| 4793 | Pain in limb | FING00001138 | 1.90 |
| 4794 | CAG-273 sp003507395 abundance in stool | GCST90032269 | 1.90 |
| 4795 | DCTN1 levels | GCST90468958 | 1.89 |
| 4796 | DAG1/F2R ratio | GCST90314374 | 1.89 |
| 4797 | Ximenoylcarnitine (C26:1) levels | GCST90200149 | 1.89 |
| 4798 | aparc-a2009s lh area S-precentral-sup-part | GCST90003365 | 1.89 |
| 4799 | GP6/TMSB10 ratio | GCST90314975 | 1.89 |
| 4800 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T281 | ECGA000281 | 1.89 |
| 4801 | Operation code - spinal laminectomy | Operations | UKBB00000564 | 1.89 |
| 4802 | TIA1/USP8 ratio | GCST90315920 | 1.89 |
| 4803 | Insomnia (standard GWA) | GCST90267286 | 1.89 |
| 4804 | F-wine liking (derived food-liking factor) | GCST90094872 | 1.89 |
| 4805 | Progressive vascular leukoencephalopathy | FING00001218 | 1.89 |
| 4806 | TGFB1 levels | GCST90470843 | 1.89 |
| 4807 | Coffee intake | Diet | UKBB00000138 | 1.89 |
| 4808 | Occlusion and stenosis of precerebral arteries (PheCode 433.1) | GCST90475986 | 1.88 |
| 4809 | rfMRI connectivity ICA-features 3 | GCST90006341 | 1.88 |
| 4810 | ESAM/VSIR ratio | GCST90314721 | 1.88 |
| 4811 | CD80 on monocyte | GCST90002039 | 1.88 |
| 4812 | TNFAIP2 levels | GCST90470896 | 1.88 |
| 4813 | wg rh intensity-contrast paracentral | GCST90003843 | 1.88 |
| 4814 | NECTIN2/VSIR ratio | GCST90315533 | 1.88 |
| 4815 | GPI levels | GCST90469391 | 1.88 |
| 4816 | CD209/GP2 ratio | GCST90313751 | 1.88 |
| 4817 | FYN levels | GCST90243200 | 1.87 |
| 4818 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T348 | ECGA000348 | 1.87 |
| 4819 | Hair colour (natural, before greying): Blonde (UKB data field 1747_1) | GCST90041836 | 1.87 |
| 4820 | DTI autoptx L3 unc l tract | GCST90385218 | 1.87 |
| 4821 | EDAR/TXNDC5 ratio | GCST90314593 | 1.87 |
| 4822 | Triacylglycerol (54:0) [NL-18:0] levels | GCST90025173 | 1.87 |
| 4823 | ANXA10 levels | GCST90468314 | 1.87 |
| 4824 | Left ventricular end diastolic volume (indexed to body surface area) | GCST90435258 | 1.86 |
| 4825 | Cancer code, self-reported - basal cell carcinoma | Medical conditions | UKBB00000117 | 1.86 |
| 4826 | CCN3/PGF ratio | GCST90313722 | 1.86 |
| 4827 | Codeine or tramadol medication | FING00000311 | 1.86 |
| 4828 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T296 | ECGU000296 | 1.86 |
| 4829 | SMOC1 levels | GCST90470682 | 1.86 |
| 4830 | Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302777 | 1.86 |
| 4831 | Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications | GCST90093113 | 1.86 |
| 4832 | 1-linoleoyl-GPI (18:2) levels | GCST90199821 | 1.86 |
| 4833 | Reaction time (standard GWA) | GCST90267296 | 1.86 |
| 4834 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 1.86 |
| 4835 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T373 | ECGU000373 | 1.85 |
| 4836 | X-21829 levels | GCST90200585 | 1.85 |
| 4837 | DTI TBSS FA External capsule R | GCST90384412 | 1.85 |
| 4838 | ITGB1BP2/MED18 ratio | GCST90315213 | 1.85 |
| 4839 | DCXR levels | GCST90468964 | 1.85 |
| 4840 | Blood cell traits latent factor 14 (red cell) | GCST90559256 | 1.85 |
| 4841 | CLEC1B/TXNDC5 ratio | GCST90314105 | 1.84 |
| 4842 | Omega-6 fatty acid levels | GCST90502503 | 1.84 |
| 4843 | Left-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302740 | 1.84 |
| 4844 | DXO levels | GCST90469055 | 1.84 |
| 4845 | aparc-DKTatlas rh area parstriangularis | GCST90003283 | 1.84 |
| 4846 | LAMP2 levels | GCST90469734 | 1.84 |
| 4847 | Never eat wheat vs no wheat restrictions (UKB data field 6144) | GCST90132932 | 1.84 |
| 4848 | TRIAP1 levels | GCST90470963 | 1.84 |
| 4849 | HIP1R levels | GCST90469453 | 1.84 |
| 4850 | SELP/VSIR ratio | GCST90315822 | 1.84 |
| 4851 | MSRA levels | GCST90469951 | 1.83 |
| 4852 | Frailty index | GCST90020053 | 1.83 |
| 4853 | Seen doctor (GP) for nerves, anxiety, tension or depression | Mental health | UKBB00000765 | 1.83 |
| 4854 | CGA levels | GCST90468732 | 1.83 |
| 4855 | Memory loss or impairment | GCST90475544 | 1.83 |
| 4856 | Omega-3 fatty acids to total fatty acids percentage | GCST90502462 | 1.83 |
| 4857 | C4 levels | GCST90281042 | 1.83 |
| 4858 | Acne (PheCode 706.1) | GCST90476211 | 1.83 |
| 4859 | METAP1D/VASH1 ratio | GCST90315429 | 1.83 |
| 4860 | IDP dMRI ProbtrackX OD fmi | GCST90004461 | 1.83 |
| 4861 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T303 | ECGA000303 | 1.83 |
| 4862 | T1 FreeSurfer a2009s rh G&S subcentral volume | GCST90385041 | 1.83 |
| 4863 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T89 | ECGA000089 | 1.83 |
| 4864 | Abdominal pain | symptoms | UKBB00000003 | 1.82 |
| 4865 | CD244/CRTAM ratio | GCST90313763 | 1.82 |
| 4866 | wg rh intensity-contrast precentral | GCST90003850 | 1.82 |
| 4867 | BLVRB/HMBS ratio | GCST90313526 | 1.82 |
| 4868 | Hashimoto thyroiditis | GCST90018635 | 1.82 |
| 4869 | AmygNuclei rh volume Paralaminar-nucleus | GCST90002666 | 1.82 |
| 4870 | ICAM2/SELE ratio | GCST90315120 | 1.82 |
| 4871 | CPXM1/MDK ratio | GCST90314221 | 1.82 |
| 4872 | DKK4/REG1A ratio | GCST90314489 | 1.82 |
| 4873 | Hair colour (natural, before greying): Light brown (UKB data field 1747_3) | GCST90041838 | 1.82 |
| 4874 | Basal cell carcinoma | GCST90013410 | 1.82 |
| 4875 | Congestive heart failure; nonhypertensive (PheCode 428) | GCST90475981 | 1.82 |
| 4876 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus L | GCST90004368 | 1.82 |
| 4877 | Types of physical activity in last 4 weeks - Light DIY (eg: pruning, watering the lawn) | Physical activity | UKBB00000871 | 1.82 |
| 4878 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374 | ECGU000374 | 1.82 |
| 4879 | EFCAB14 levels | GCST90469076 | 1.82 |
| 4880 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T452 | ECGA000452 | 1.81 |
| 4881 | BSG/LY9 ratio | GCST90313534 | 1.81 |
| 4882 | Glycerate levels | GCST90200290 | 1.81 |
| 4883 | aparc-Desikan rh volume parsopercularis | GCST90002818 | 1.81 |
| 4884 | Calcific tendinitis of shoulder | FING00000235 | 1.81 |
| 4885 | Psoriasis | GCST90468147 | 1.81 |
| 4886 | Free cholesterol levels in small VLDL | GCST90092972 | 1.81 |
| 4887 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T425 | ECGA000425 | 1.81 |
| 4888 | PILRA levels | GCST90470236 | 1.81 |
| 4889 | TYMP levels | GCST90470996 | 1.81 |
| 4890 | BOLA2 or BOLA2B levels | GCST90468460 | 1.81 |
| 4891 | EDAR levels | GCST90469068 | 1.80 |
| 4892 | Left ventricular end systole anterior wall thickness | GCST90278512 | 1.80 |
| 4893 | IDP dMRI TBSS MD Posterior corona radiata L | GCST90004054 | 1.80 |
| 4894 | IDP dMRI ProbtrackX L2 ar r | GCST90004274 | 1.80 |
| 4895 | ITIH4 levels | GCST90469651 | 1.80 |
| 4896 | Zoster infection | GCST90018721 | 1.80 |
| 4897 | IDP dMRI TBSS L3 Cingulum cingulate gyrus R | GCST90004205 | 1.80 |
| 4898 | DCTN1/SCAMP3 ratio | GCST90314433 | 1.80 |
| 4899 | BIRC2/CD40LG ratio | GCST90313517 | 1.80 |
| 4900 | IRAK1/NFATC1 ratio | GCST90315194 | 1.80 |
| 4901 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T278 | ECGA000278 | 1.80 |
| 4902 | F-sweet food liking (derived food-liking factor) | GCST90094854 | 1.80 |
| 4903 | GHRL levels | GCST90469341 | 1.80 |
| 4904 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T312 | ECGU000312 | 1.79 |
| 4905 | PGR levels | GCST90470223 | 1.79 |
| 4906 | IDP dMRI TBSS L2 Anterior corona radiata R | GCST90004145 | 1.79 |
| 4907 | IDP dMRI ProbtrackX ICVF mcp | GCST90004391 | 1.79 |
| 4908 | Free cholesterol in very small VLDL | GCST90500777 | 1.79 |
| 4909 | CC2D1A/STAMBP ratio | GCST90313664 | 1.79 |
| 4910 | SERPINB1 levels | GCST90470589 | 1.79 |
| 4911 | CA2/CA3 ratio | GCST90313576 | 1.79 |
| 4912 | SMPDL3A levels | GCST90470686 | 1.78 |
| 4913 | Treatment/medication code - paracetamol | Medications | UKBB00000853 | 1.78 |
| 4914 | STX4 levels | GCST90470772 | 1.78 |
| 4915 | Age high blood pressure diagnosed | Medical conditions | UKBB00000016 | 1.78 |
| 4916 | CD55/PTGDS ratio | GCST90313847 | 1.78 |
| 4917 | IDP dMRI TBSS L3 Inferior cerebellar peduncle R | GCST90004181 | 1.78 |
| 4918 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87 | ECGA000087 | 1.78 |
| 4919 | HSPA1A levels | GCST90469487 | 1.78 |
| 4920 | IDP T1 FAST ROIs L cerebellum VIIb | GCST90002575 | 1.78 |
| 4921 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T307 | ECGA000307 | 1.78 |
| 4922 | Other infective otitis externa | FING00001060 | 1.78 |
| 4923 | B4GALT1 levels | GCST90468412 | 1.78 |
| 4924 | Flat foot [pes planus] (acquired) | FING00000545 | 1.78 |
| 4925 | CST3/TFF3 ratio | GCST90314299 | 1.78 |
| 4926 | CST6/FABP9 ratio | GCST90314301 | 1.77 |
| 4927 | Total esterified cholesterol levels | GCST90500034 | 1.77 |
| 4928 | Free cholesterol in small VLDL | GCST90499817 | 1.77 |
| 4929 | TNFRSF11A levels | GCST90277644 | 1.77 |
| 4930 | GZMA levels | GCST90241323 | 1.77 |
| 4931 | Total testosterone levels | GCST90239819 | 1.77 |
| 4932 | Diseases of the digestive system | FING00000429 | 1.77 |
| 4933 | DTI autoptx MD ilf l tract | GCST90385234 | 1.77 |
| 4934 | COX5B levels | GCST90468834 | 1.77 |
| 4935 | Androstenediol (3alpha, 17alpha) monosulfate (3) levels | GCST90199856 | 1.77 |
| 4936 | Hippocampal subfield left CA4 volume (head) | GCST90267943 | 1.77 |
| 4937 | Essential tremor (PheCode 333.1) | GCST90475832 | 1.77 |
| 4938 | CLEC14A/EPHB4 ratio | GCST90314079 | 1.76 |
| 4939 | ACOT13 levels | GCST90468200 | 1.76 |
| 4940 | REST UKBBICA NODEamps25 0009 | GCST90385492 | 1.76 |
| 4941 | Hammer toe (acquired) (PheCode 735.21) | GCST90476250 | 1.76 |
| 4942 | Glutamine levels | GCST90092818 | 1.76 |
| 4943 | PLXNB2/SEMA7A ratio | GCST90315692 | 1.76 |
| 4944 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditions | UKBB00000101 | 1.76 |
| 4945 | ANXA1 levels | GCST90468316 | 1.76 |
| 4946 | Ulcerative enterocolitis | FING00001391 | 1.76 |
| 4947 | IRAK1 levels | GCST90469627 | 1.76 |
| 4948 | CALB2 levels | GCST90468527 | 1.76 |
| 4949 | HSPB1 levels | GCST90179317 | 1.76 |
| 4950 | CCN5 levels | GCST90468591 | 1.76 |
| 4951 | ADAMTS8 levels | GCST90468227 | 1.76 |
| 4952 | Word interpolation | Fluid intelligence / reasoning | UKBB00000918 | 1.75 |
| 4953 | Diffuse idiopathic skeletal hyperostosis flow score | GCST90134532 | 1.75 |
| 4954 | HS6ST2 levels | GCST90469480 | 1.75 |
| 4955 | Sphingomyelin_42:2_[M+H]1+ levels | GCST90060403 | 1.75 |
| 4956 | GOPC levels | GCST90469377 | 1.75 |
| 4957 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 1.75 |
| 4958 | Asthma | GCST90475259 | 1.75 |
| 4959 | DKK1/VEGFC ratio | GCST90314484 | 1.75 |
| 4960 | Graves' disease (PheCode 242.1) | GCST90475644 | 1.75 |
| 4961 | DTI TBSS L2 Uncinate fasciculus L | GCST90384521 | 1.75 |
| 4962 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T291 | ECGA000291 | 1.75 |
| 4963 | DLK1/RGMB ratio | GCST90314493 | 1.75 |
| 4964 | Physical activity | GCST90093323 | 1.75 |
| 4965 | IL1R2/MEGF9 ratio | GCST90315159 | 1.75 |
| 4966 | BLNK levels | GCST90468448 | 1.75 |
| 4967 | Second line medication for Crohn's disease | FING00001284 | 1.74 |
| 4968 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T372 | ECGU000372 | 1.74 |
| 4969 | Treatment/medication code - simvastatin | Medications | UKBB00000859 | 1.74 |
| 4970 | IDP dMRI TBSS L2 Superior longitudinal fasciculus L | GCST90004164 | 1.74 |
| 4971 | Takes medication for skin cancer? | GCST90475190 | 1.74 |
| 4972 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T371 | ECGU000371 | 1.74 |
| 4973 | LDL direct | Blood biochemistry | UKBB00000386 | 1.74 |
| 4974 | PPP3R1 levels | GCST90470307 | 1.74 |
| 4975 | LDL cholesterol | GCST000759 | 1.74 |
| 4976 | Glutamine levels | GCST90497285 | 1.74 |
| 4977 | B4GALT1/B4GAT1 ratio | GCST90313429 | 1.74 |
| 4978 | Vanillactate levels | GCST90199978 | 1.74 |
| 4979 | Diseases of oesophagus, stomach and duodenum | FING00000428 | 1.74 |
| 4980 | STK4 levels | GCST90470767 | 1.74 |
| 4981 | CX3CL1/RGMB ratio | GCST90314327 | 1.73 |
| 4982 | INSR levels | GCST90241509 | 1.73 |
| 4983 | HEXIM1/IKBKG ratio | GCST90315045 | 1.73 |
| 4984 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 1.73 |
| 4985 | ABHD14B/APRT ratio | GCST90313137 | 1.73 |
| 4986 | LPO levels | GCST90241730 | 1.73 |
| 4987 | IDP dMRI TBSS L3 Cingulum cingulate gyrus L | GCST90004206 | 1.73 |
| 4988 | CRTAM/LY9 ratio | GCST90314278 | 1.73 |
| 4989 | Deoxycholic acid glucuronide metabolite level | GCST90616229 | 1.73 |
| 4990 | APP/VEGFC ratio | GCST90313333 | 1.73 |
| 4991 | HMBS/PSMG3 ratio | GCST90315064 | 1.73 |
| 4992 | Total lipid levels in medium LDL | GCST90092910 | 1.72 |
| 4993 | ENO2/MGLL ratio | GCST90314663 | 1.72 |
| 4994 | Bifidobacterium catenulatum abundance in stool | GCST90032224 | 1.72 |
| 4995 | Abdominal fat ratio | GCST90267360 | 1.72 |
| 4996 | Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586) | GCST90269683 | 1.72 |
| 4997 | MAVS/RNF41 ratio | GCST90315395 | 1.72 |
| 4998 | aparc-Desikan rh area parstriangularis | GCST90003126 | 1.72 |
| 4999 | Severe autoimmune type 2 diabetes | GCST90026412 | 1.72 |
| 5000 | LDL (standard GWA) | GCST90267272 | 1.72 |